StockData

KALA BIO, Inc. (KALA) stock

KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 5/30
$0.19+0.00 (+1.42%)

Close on Oct 19, 2026Market cap $14.28KP/E –Yield –

Kala Bio gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2019Mar 31, 2019$1.15M–

More Kala Bio figures

See a number that looks wrong?